C. Noblet
Impact in
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 2
- Pharmacology and Obesity Treatment 2
- Surgery 5
- Lipoproteins and Cardiovascular Health 3
- Pancreatic function and diabetes 1
- Co-authors
- Nicholas Moore (5 shared papers)Christian Thuillez (3 shared papers)I. Marie (3 shared papers)Nathalie Massy (2 shared papers)C. Kreft-Jaïs (2 shared papers)Michel Ollagnier (2 shared papers)Nicholas M. Moore (2 shared papers)Françoise Haramburu (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (2 papers)Journal of the American Academy of Dermatology (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)Clinical Endocrinology (1 paper)Arthritis Care & Research (1 paper)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
C. Noblet
15 papers receiving 597 citations
Peers
Comparison fields: 5 of 86
- Toxicology 280
- Geriatrics and Gerontology 156
- Orthopedics and Sports Medicine 76
- Pharmacology 148
- Pediatrics, Perinatology and Child Health 149
Countries citing papers authored by C. Noblet
This map shows the geographic impact of C. Noblet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Noblet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Noblet more than expected).
Fields of papers citing papers by C. Noblet
This network shows the impact of papers produced by C. Noblet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Noblet. The network helps show where C. Noblet may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Noblet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 247 | |
| 2 | 2008 | 127 | |
| 3 | 1997 | 108 | |
| 4 | [French pharmacovigilance database system: examples of utilisation]. | 1996 | 52 |
| 5 | 2004 | 34 | |
| 6 | 1995 | 24 | |
| 7 | [Focus on the safety of ibuprofen at the analgesic-antipyretic dose]. | 1997 | 15 |
| 8 | 1991 | 8 | |
| 9 | 1996 | 6 | |
| 10 | Severe polyarthropathy in an adolescent treated with pefloxacin. | 1991 | 5 |
| 11 | [Spontaneous hematoma: thoughts about selective serotonin uptake inhibitors]. | 2000 | 2 |
| 12 | 2010 | 1 | |
| 13 | Renal failure with fluoroquinolones. | 1997 | 1 |
| 14 | [Hypoaldosteronism induced by low molecular weight heparins]. | 1991 | 1 |
| 15 | 2008 | 1 | |
| 16 | [Megaloblastic anemia secondary to ingestion of metformin]. | 1991 | 1 |
| 17 | [2 epidemics of acute kidney failure caused by piromidic acid]. | 1989 | 0 |
About C. Noblet
C. Noblet is a scholar working on Pharmacology, Surgery, Molecular Biology, Pharmacology and Physiology, having authored 17 papers that have together received 633 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Poisoning and overdose treatments (2 papers), Blood disorders and treatments (2 papers), Pharmacology and Obesity Treatment (2 papers), Pancreatic function and diabetes (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Toxicology (280 citations), Geriatrics and Gerontology (156 citations), Orthopedics and Sports Medicine (76 citations), Pharmacology (148 citations) and Pediatrics, Perinatology and Child Health (149 citations). C. Noblet has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Nicholas Moore, Christian Thuillez, I. Marie, Nathalie Massy, C. Kreft-Jaïs, Michel Ollagnier, Nicholas M. Moore, Françoise Haramburu, Michel Andréjak and Bernard Bégaud. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of the American Academy of Dermatology, European Journal of Gastroenterology & Hepatology, Clinical Endocrinology and Arthritis Care & Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.